Atara Biotherap (ATRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 120,772 | 128,940 | 8,573 | 63,573 | 20,340 |
| Cost of Goods | 21,212 | 21,009 | 8,886 | N/A | N/A |
| Gross Profit | 99,560 | 107,931 | -313 | 63,573 | 20,340 |
| Operating Expenses | 63,910 | 191,378 | 276,579 | 344,086 | 360,802 |
| Operating Income | 35,862 | -83,438 | -276,006 | -280,513 | -340,462 |
| Interest Expense | 3,792 | 4,615 | 5,285 | 373 | 0 |
| Other Income | 649 | 2,638 | 5,180 | 52,596 | 367 |
| Pre-tax Income | 32,719 | -85,415 | -276,111 | -228,290 | -340,095 |
| Income Tax | 31 | -12 | 15 | 12 | 46 |
| Net Income Continuous | 32,688 | -85,403 | -276,126 | -228,302 | -340,141 |
| Net Income | $32,688 | $-85,403 | $-276,126 | $-228,302 | $-340,141 |
| EPS Basic Total Ops | 2.61 | -11.41 | -65.19 | -56.00 | -90.75 |
| EPS Basic Continuous Ops | 2.61 | -11.41 | -65.19 | -55.96 | -90.78 |
| EPS Diluted Total Ops | 2.57 | -11.41 | -65.19 | -56.00 | -90.75 |
| EPS Diluted Continuous Ops | 2.57 | -11.41 | -65.19 | -55.96 | -90.78 |
| EPS Diluted Before Non-Recurring Items | N/A | -11.41 | -65.25 | -68.25 | -90.75 |
| EBITDA(a) | $38,237 | $-78,627 | $-270,385 | $-273,836 | $-329,348 |